Clinical trial
Effects of Detraining in Endurance Athletes With Atrial Fibrillation (NEXAF Detraining)
NCT04991337 is registered in ClinicalTrials.gov with Vestre Viken Hospital Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Detraining in Endurance Athletes With Atrial Fibrillation (NEXAF Detraining)
- Lead sponsor
- Vestre Viken Hospital Trust
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 5, 2022
- Completion date
- January 1, 2024
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.